Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beom-Soo Shin

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|August 11, 2007
Development of LC/MS/MS assay for the determination of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazine-1-sulfonyl]-2-propoxyphenyl}-7-propyl-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one (SK3530) in human plasma: application to a clinical pharmacokinetic studyBeom Soo Shin, Seul Ki Hu, John Kim, et al.
Chinese Journal of Integrative Medicine|January 17, 2018
Alterations of Gefitinib Pharmacokinetics by Co-administration of Herbal Medications in RatsKwon-Yeon Weon, Min Gi Kim, Soyoung Shin, et al.
Journal of Pharmacological Sciences|December 22, 2018
Reduced variability in tacrolimus pharmacokinetics following intramuscular injection compared to oral administration in cynomolgus monkeys: Investigating optimal dosing regimensKyo Won Lee, Tae Hwan Kim, Jong Bong Lee, et al.
Antiviral Therapy|February 17, 2007
A randomized placebo-controlled, dose-finding study of oral LB80380 in HBeAg-positive patients with chronic hepatitis BMan-Fung Yuen, John Kim, Chung Ryeol Kim, et al.
Pharmaceutical Research|May 6, 2015
Modulation of Pharmacokinetic and Cytotoxicity Profile of Imatinib Base by Employing Optimized Nanostructured Lipid CarriersBiki Gupta, Bijay Kumar Poudel, Tuan Hiep Tran, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modelingJürgen B Bulitta, Neang S Ly, Cornelia B Landersdorfer, et al.
Chemotherapy|May 21, 2011
Population pharmacokinetics of a novel histone deacetylase inhibitor, cyclo{(2S)-2-amino-8-[(aminocarbonyl)hydrazono] decanoyl-1-L-tryptophyl-L-isoleucyl-(2R)-2-piperidinecarbonyl} (SD-2007), and its metabolic conversion to apicidin after intravenous injection and oral administration in ratsBeom Soo Shin, Jürgen B Bulitta, Deok Ki Hong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 20, 2014
Quantitative determination of absorption and first-pass metabolism of apicidin, a potent histone deacetylase inhibitorBeom Soo Shin, Sun Dong Yoo, Tae Hwan Kim, et al.
Archives of Pharmacal Research|November 10, 2012
Pharmacokinetics and tissue distribution of psammaplin A, a novel anticancer agent, in miceHak Jae Kim, Tae Hwan Kim, Won Sik Seo, et al.
Talanta|October 5, 2014
Determination of acrylamide and glycidamide in various biological matrices by liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic studyTae Hwan Kim, Soyoung Shin, Kyu Bong Kim, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
Journal of Pharmaceutical and Biomedical Analysis|August 11, 2007
Development of LC/MS/MS assay for the determination of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazine-1-sulfonyl]-2-propoxyphenyl}-7-propyl-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one (SK3530) in human plasma: application to a clinical pharmacokinetic studyBeom Soo Shin, Seul Ki Hu, John Kim, et al.
Chinese Journal of Integrative Medicine|January 17, 2018
Alterations of Gefitinib Pharmacokinetics by Co-administration of Herbal Medications in RatsKwon-Yeon Weon, Min Gi Kim, Soyoung Shin, et al.
Journal of Pharmacological Sciences|December 22, 2018
Reduced variability in tacrolimus pharmacokinetics following intramuscular injection compared to oral administration in cynomolgus monkeys: Investigating optimal dosing regimensKyo Won Lee, Tae Hwan Kim, Jong Bong Lee, et al.
Antiviral Therapy|February 17, 2007
A randomized placebo-controlled, dose-finding study of oral LB80380 in HBeAg-positive patients with chronic hepatitis BMan-Fung Yuen, John Kim, Chung Ryeol Kim, et al.
Pharmaceutical Research|May 6, 2015
Modulation of Pharmacokinetic and Cytotoxicity Profile of Imatinib Base by Employing Optimized Nanostructured Lipid CarriersBiki Gupta, Bijay Kumar Poudel, Tuan Hiep Tran, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modelingJürgen B Bulitta, Neang S Ly, Cornelia B Landersdorfer, et al.
Chemotherapy|May 21, 2011
Population pharmacokinetics of a novel histone deacetylase inhibitor, cyclo{(2S)-2-amino-8-[(aminocarbonyl)hydrazono] decanoyl-1-L-tryptophyl-L-isoleucyl-(2R)-2-piperidinecarbonyl} (SD-2007), and its metabolic conversion to apicidin after intravenous injection and oral administration in ratsBeom Soo Shin, Jürgen B Bulitta, Deok Ki Hong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 20, 2014
Quantitative determination of absorption and first-pass metabolism of apicidin, a potent histone deacetylase inhibitorBeom Soo Shin, Sun Dong Yoo, Tae Hwan Kim, et al.
Archives of Pharmacal Research|November 10, 2012
Pharmacokinetics and tissue distribution of psammaplin A, a novel anticancer agent, in miceHak Jae Kim, Tae Hwan Kim, Won Sik Seo, et al.
Talanta|October 5, 2014
Determination of acrylamide and glycidamide in various biological matrices by liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic studyTae Hwan Kim, Soyoung Shin, Kyu Bong Kim, et al.
Pageof 16